Published in Am J Public Health on May 01, 1996
Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics (2013) 1.45
Prenatal screening for cystic fibrosis carriers: an economic evaluation. Am J Hum Genet (1998) 0.84
Is non-directive genetic counselling possible? Lancet (1991) 3.53
Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med (1992) 3.12
Knowing for the sake of knowing: the value of prognostic information. Med Decis Making (1990) 2.27
Linkage disequilibrium, cystic fibrosis, and genetic counseling. Am J Hum Genet (1989) 2.19
Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol (1993) 1.78
Substituting diagnostic services. New tests only partly replace older ones. JAMA (1989) 1.64
Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women. Am J Public Health (1992) 1.32
A child with cystic fibrosis: II. Subsequent family planning decisions, reproduction and use of prenatal diagnosis. Clin Genet (1990) 1.20
The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol (1994) 1.15
Prenatal diagnosis of cystic fibrosis by microvillar enzyme assay on a sequence of 258 pregnancies. Hum Genet (1988) 1.10
Prenatal diagnosis of cystic fibrosis using linked DNA markers and microvillar intestinal enzyme analysis. Hum Genet (1987) 1.00
The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations. Milbank Q (1992) 0.96
Costs and benefits of prenatal screening for cystic fibrosis. Med Care (1991) 0.92
Prenatal diagnosis of cystic fibrosis: microvillar enzymes and DNA analysis compared. Clin Chem (1988) 0.91
Attitudes toward abortion among parents of children with cystic fibrosis. Am J Public Health (1991) 0.89
Prognostic information versus accuracy: once more with meaning. Med Decis Making (1991) 0.79
Clinical guidelines for using two dichotomous tests. Med Decis Making (1986) 0.79
Multiple test analyzer (MTA): a microcomputer program for determining preferred strategies with two diagnostic tests. Med Decis Making (1986) 0.79
Clarification needed to cystic fibrosis model. Am J Obstet Gynecol (1993) 0.78
Response rates to mail surveys published in medical journals. J Clin Epidemiol (1997) 21.55
Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA (1999) 11.19
How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? N Engl J Med (1989) 5.77
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Mortality and duration of hemodialysis treatment. JAMA (1991) 2.94
Physician response to fee changes with multiple payers. J Health Econ (1991) 2.92
Medical staff characteristics and hospital costs. J Hum Resour (1978) 2.69
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N Engl J Med (1991) 2.46
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med (1990) 2.43
Knowing for the sake of knowing: the value of prognostic information. Med Decis Making (1990) 2.27
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone. Br J Pharmacol (2008) 2.13
Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med (1988) 2.11
A re-examination of the meaning and importance of supplier-induced demand. J Health Econ (1994) 2.08
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Making sense out of utilization data. Med Care (1975) 1.98
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol (1993) 1.78
Taxation, health insurance, and market failure in the medical economy. J Econ Lit (1986) 1.76
Tax credits for health insurance and medical savings accounts. Health Aff (Millwood) (1995) 1.62
Outcome bias in decision evaluation. J Pers Soc Psychol (1988) 1.58
A new approach to hospital cost functions and some issues in revenue regulation. Health Care Financ Rev (1983) 1.58
Pregnancy outcome of patients with uncorrected uterine anomalies managed in a high-risk obstetric setting. Obstet Gynecol (1990) 1.57
Toward new typologies for HMOs. Milbank Q (1990) 1.56
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Omission bias and pertussis vaccination. Med Decis Making (1994) 1.48
Assessing physicians' estimates of the probability of coronary artery disease: the influence of patient characteristics. Med Decis Making (1992) 1.42
The illusion of deterministic rules. Ann Intern Med (1997) 1.39
Contractual arrangements between HMOs and primary care physicians: three-tiered HMOs and risk pools. Med Care (1992) 1.35
Patient compliance with antihypertensive medication. Am J Public Health (1980) 1.34
Why some health policies don't make sense at the bedside. Ann Intern Med (1995) 1.30
Factors affecting the use of physician services in a rural community. Am J Public Health (1976) 1.29
Health maintenance organizations and hospital quality for coronary artery bypass surgery. Med Care Res Rev (1999) 1.25
Nonprofit firms in medical markets. Am Econ Rev (1987) 1.22
What is unnecessary surgery? Milbank Mem Fund Q Health Soc (1979) 1.20
First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy. J Clin Oncol (1998) 1.19
What is adverse about adverse selection? Adv Health Econ Health Serv Res (1985) 1.19
The impact of computer-assisted test interpretation on physician decision making: the case of electrocardiograms. Med Decis Making (1997) 1.18
Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol (1994) 1.18
The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care (1992) 1.17
Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem (1997) 1.16
Comorbidity-adjusted complication risk: a new outcome quality measure. Med Care (1996) 1.16
Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA (1996) 1.13
Incentive effects of medical malpractice. The effects of malpractice litigation on physicians' fees and incomes. Am Econ Rev (1990) 1.12
Is cream-skimming a problem for the competitive medical market? J Health Econ (1984) 1.10
Neural tube defects: issues in prenatal diagnosis and counselling. Obstet Gynecol (1986) 1.08
Returns on equity for not-for-profit hospitals. Health Serv Res (1986) 1.07
Hospital output forecasts and the cost of empty hospital beds. Health Serv Res (1986) 1.05
Health maintenance organization penetration and the practice location choices of new physicians: a study of large metropolitan areas in the United States. Med Care (1998) 1.05
Analysis of capacity decisions for progressive patient care hospital facilities. Health Serv Res (1980) 1.05
A stochastic service network model with application to hospital facilities. Oper Res (1981) 1.04
Recurrence rate for de novo 21q21q translocation Down syndrome: a study of 112 families. Am J Med Genet (1984) 1.03
The use of an information system for community health services planning and management. Med Care (1975) 1.03
Market power, monopsony, and health insurance markets. J Health Econ (1988) 1.03
Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein. Proc Natl Acad Sci U S A (1998) 1.02
Human erythrocyte galactokinase and galactose-1-phosphate uridylyltransferase: a population survey. Am J Hum Genet (1975) 1.00
Determinants of priority for risk reduction: the role of worry. Risk Anal (2000) 0.99
Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am J Obstet Gynecol (1987) 0.99
Derived thresholds. Determining the diagnostic probabilities at which clinicians initiate testing and treatment. Med Decis Making (1983) 0.99
Price of dialysis, unit staffing, and length of dialysis treatments. Am J Kidney Dis (1990) 0.98
Premium variation in the individual health insurance market. Int J Health Care Finance Econ (2001) 0.98
Galactose tolerance studies of individuals with reduced galactose pathway activity. Am J Hum Genet (1975) 0.97
Molecular detection of a Yp/18 translocation in a 45,X holoprosencephalic male. Hum Genet (1988) 0.95
Financial incentives and drug spending in managed care. Health Aff (Millwood) (1999) 0.95
Use of umbilical cord blood culture for detection of neonatal bacteremia. Obstet Gynecol (1981) 0.95
The public's attitudes toward incentives for organ donation. Transplant Proc (1999) 0.95
The limits of suffering: critical care nurses' views of hospital care at the end of life. Soc Sci Med (1997) 0.94
Hospital adoption of medical technology: an empirical test of alternative models. Health Serv Res (1995) 0.94
Measuring the economic impact of perioperative total parenteral nutrition: principles and design. Am J Clin Nutr (1988) 0.93
Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care. Med Care (1998) 0.93
How will changes in physician payment by Medicare influence laboratory testing? JAMA (1987) 0.92
Health insurance under competition: would people choose what is expected? Inquiry (1984) 0.91
The origin of increased serum iron in pregnancy-induced hypertension. Am J Obstet Gynecol (1987) 0.91
Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? Med Decis Making (1998) 0.91
Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancer. J Clin Oncol (1998) 0.90
Antepartum fetal evaluation by maternal perception of fetal movement. Obstet Gynecol (1982) 0.90
Cerebrospinal fluid shunts in pregnancy. Report of two cases and review of the literature. Am J Perinatol (1988) 0.90
HMO managers' views on financial incentives and quality. Health Aff (Millwood) (1991) 0.89
Measuring community benefits provided by for-profit and nonprofit hospitals. Health Aff (Millwood) (2001) 0.88
Physician payment reform: who shall be paid? Med Care Rev (1986) 0.88
Association of dialyzer reuse with hospitalization and survival rates among U.S. hemodialysis patients: do comorbidities matter? J Clin Epidemiol (1999) 0.88
Primary care physician turnover in HMOs. Health Serv Res (1994) 0.88
Ranking hospitals by the quality of care for medical conditions: the role of complications. Trans Am Clin Climatol Assoc (1996) 0.87
Second trimester diagnosis of fetal skeletal dysplasias. Obstet Gynecol Surv (1987) 0.86
Does cesarean section decrease the incidence of major birth trauma? J Perinatol (1998) 0.86
Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump. J Reprod Med (1982) 0.86
Fetal-maternal bleeding associated with genetic amniocentesis. Obstet Gynecol (1980) 0.85
Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol (1987) 0.85
Primary management of postpartum vulvovaginal hematomas by angiographic embolization. Am J Perinatol (1985) 0.84
How important is the scientific literature in guiding clinical decisions? The case of magnetic resonance imaging. Int J Technol Assess Health Care (1993) 0.84
An evaluation of cytogenetic analysis as a primary tool in the assessment of recurrent pregnancy wastage. Obstet Gynecol (1978) 0.83
A model for making project funding decisions at the National Cancer Institute. Oper Res (1993) 0.83
Carrier screening for cystic fibrosis: costs and clinical outcomes. Med Decis Making (1998) 0.83